CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Drug Deactivation Devices for Disposal of Pain Medications: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Last updated: December 7, 2020
Project Number: RB1531-000
Product Line: Rapid Response
Research Type: Device
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of at-home drug deactivation and disposal devices for unused medication in preventing harm to patients and/or household contacts?
  2. What is the cost-effectiveness of at-home drug deactivation and disposal devices for unused medication in preventing harm to patients and/or household contacts?
  3. What are the evidence-based guidelines regarding the use of at-home drug deactivation and disposal devices for unused medication in preventing harm to patients and/or household contacts?

Key Message

No evidence was identified regarding the clinical effectiveness, cost-effectiveness, or evidence-based guidelines of at-home drug deactivation and disposal devices for unused medication in preventing harm to patients and/or household contacts.